Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
Dallman
P R
PR
Department of Pediatrics, University of California, San Francisco School of Medicine.
D000751:Anemia, Neonatal / Q000517:prevention & control / Q000628:therapy*; D001803:Blood Transfusion; D000075202:Contraindications; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000517:prevention & control / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin